News - Archive

Ruconest – the first recombinant C1 inhibitor for the treatment of HAE attacks

The European Commisioin has granted Pharming Marketing Authorization for its lead product Ruconest for the treatment of acute attacks of Hereditary Angioedema. Ruconest is now approved for use in the 27 EU countries including Romania, plus Norway, Iceland and Liechtenstein. Patients suffering from HAE experience unpredictable, painful and debilitating attacks, due to reduced levels of C1 inhibitor, resulting in intense swelling of parts of the body (for example, face, throat, abdomen) which can last up to five days if left untreated.

The 22nd World Allergy Congress, Cancun, Mexico 2011

World allergy congress MexicoThe 22nd World Allergy Congress is the biennial scientific meeting of the World Allergy Organization (WAO) which will take place in Cancun, Mexico, 4-8 December 2011. As a global alliance of national and regional allergy, asthma and clinical immunology societies, WAO proudly partners with its member societies to host its biennial Congress. In 2011, WAO and its World Allergy Congress will also be host to the annual meetings of the Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology (COMPEDIA) and the Mexican College of Clinical Immunology and Allergy (CMICA).

The 2nd Congress of the Romanian Allergology and Clinical Imunology Society, Cluj, Romania 2011

The 2nd Congress of the Romanian Allergology and Clinical Imunology Society will be held between 6-8th May 2011, in Cluj-Napoca, Romania. The Congress is organized under the patronage of the Romanian Allergology and Clinical Imunology Society.

Venue of the Congress: City Plaza Hotel, Str. Sindicatelor nr. 9-11, Cluj-Napoca, Romania.